XTX Topco’s Medicus Pharma MDCX Stock Holding History

XTX Topco’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Buy	+243,362	New	+$86.2K	﹤0.01%	3504

Other funds holding MDCX

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MHC

May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

XTX Topco's MDCX Position: Q2 2026 in Review

XTX Topco opened a new position in Medicus Pharma (MDCX) in Q2 2026: 243,362 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #3504 among its holdings.

24 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

XTX Topco held 243,362 shares of Medicus Pharma worth $109K as of Q2 2026.
Medicus Pharma was a new XTX Topco position in Q2 2026.
Medicus Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3504 holding.
24 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.